{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:10:04Z","timestamp":1749006604330,"version":"3.41.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.prp.2025.156031","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:47:36Z","timestamp":1747982856000},"page":"156031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression of TIM-3 in transitional cell carcinoma: A comparative study of tissue and serum levels"],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0165-5930","authenticated-orcid":false,"given":"Farrukh","family":"Siddique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-8604","authenticated-orcid":false,"given":"Naveed","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleha","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Siffat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2025.156031_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156031_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/his.13752","article-title":"Variants and new entities of bladder cancer","volume":"74","author":"Lopez-Beltran","year":"2019","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.prp.2025.156031_bib3","first-page":"625","article-title":"National Cancer Registry of Pakistan: first comprehensive report of cancer statistics 2015-2019","volume":"33","author":"Ikram","year":"2023","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"7","key":"10.1016\/j.prp.2025.156031_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijerph21070954","article-title":"Risk factors associated with urothelial bladder cancer","volume":"21","author":"Alouini","year":"2024","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"11","key":"10.1016\/j.prp.2025.156031_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153186","article-title":"Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations","volume":"216","author":"Hodgson","year":"2020","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2025.156031_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155997","article-title":"Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer","volume":"270","author":"Lima","year":"2025","journal-title":"Pathol. - Res. Pract."},{"issue":"8","key":"10.1016\/j.prp.2025.156031_bib7","article-title":"Comparison of outcomes between radical radiotherapy and radical cystectomy in muscle invasive bladder cancer in a cancer specialized unit of a developing country","volume":"12","author":"Fiaz","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.prp.2025.156031_bib8","article-title":"Outcomes of BCG induction in high-risk non-muscle-invasive bladder cancer patients (NMIBC): a retrospective cohort study","volume":"9","author":"Pirzada","year":"2017","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.prp.2025.156031_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.12669\/pjms.302.4117","article-title":"SJ. Factors effecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG","volume":"30","author":"Khan","year":"2014","journal-title":"Pak. J. Med Sci."},{"issue":"15_","key":"10.1016\/j.prp.2025.156031_bib10","article-title":"Trend in the use of neo-adjuvant chemotherapy for the management of muscle invasive bladder cancer at a major tertiary care hospital in Pakistan","volume":"37","author":"Jabbar","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156031_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155468","article-title":"Expression of immune checkpoint molecules TIGIT and TIM-3 by tumor-infiltrating lymphocytes predicts poor outcome in sinonasal mucosal melanoma","volume":"260","author":"Ledderose","year":"2024","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2025.156031_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154632","article-title":"New immunotherapeutic approaches for cancer treatment","volume":"248","author":"Kamrani","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2025.156031_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155864","article-title":"Exploring immune checkpoint inhibitors: focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Aden","year":"2025","journal-title":"Pathol. - Res. Pract."},{"issue":"7","key":"10.1016\/j.prp.2025.156031_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2025.156031_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115445","article-title":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases","volume":"209","author":"Bailly","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2025.156031_bib16","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma","author":"Chen","year":"2021"},{"issue":"4","key":"10.1016\/j.prp.2025.156031_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jso.24012","article-title":"T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: clinicopathologic correlations and association with survival","volume":"112","author":"Yang","year":"2015","journal-title":"J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2025.156031_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2217\/fon-2021-1379","article-title":"The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma","volume":"18","author":"Lu","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.prp.2025.156031_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CMAR.S162478","article-title":"Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.prp.2025.156031_bib20","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.2147\/CMAR.S328312","article-title":"Clinical value of combined detection of serum sTim-3 and pepsinogen for gastric cancer diagnosis","volume":"13","author":"Chen","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.prp.2025.156031_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0391560319887327","article-title":"Spotlight on gender-specific disparities in bladder cancer","volume":"87","author":"Mancini","year":"2020","journal-title":"Urologia"},{"issue":"2","key":"10.1016\/j.prp.2025.156031_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11255-006-6676-1","article-title":"Clinico-pathological features of bladder carcinoma: experience from a tertiary care hospital of Pakistan","volume":"38","author":"Rafique","year":"2006","journal-title":"Int. Urol. Nephrol."},{"issue":"6","key":"10.1016\/j.prp.2025.156031_bib23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00262-019-02340-w","article-title":"Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy","volume":"68","author":"Holland","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2025.156031_bib24","first-page":"790","article-title":"Transitional cell carcinoma of the urinary bladder: a clinicopathological study","volume":"49","author":"Matalka","year":"2008","journal-title":"Singap. Med. J."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:30:36Z","timestamp":1749004236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"alternative-id":["S0344033825002249"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156031","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of TIM-3 in transitional cell carcinoma: A comparative study of tissue and serum levels","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156031"}}